MedComm – Oncology : Impact Factor & More
eISSN: 2769-6448
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
MedComm – Oncology Journal Specifications
Indexed in the following public directories
DOAJ
| Overview | |
| Publisher | Wiley |
| Language | English |
| Article Processing Charges | USD 2800 |
| Publication Time | 15 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Sichuan International Medical Exchange & Promotion Association (SCIMEA) |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers in MedComm – Oncology
The Dual Role of Autophagy in Cancer: Mechanisms and Therapeutic Strategies
- 24 Apr 2026
- MedComm – Oncology
X‐Linked Inhibitor of Apoptosis Protein (XIAP) Contributes to ERK1/2‐Mediated Anoikis Resistance in Hepatocellular Carcinoma
- 1 Mar 2026
- MedComm – Oncology
Multifacet Roles of Cellular Senescence in Cancer: Mechanisms and Therapeutic Implications
- 1 Mar 2026
- MedComm – Oncology
Title not available
- 1 Mar 2026
- MedComm – Oncology
The Role of One‐Carbon Metabolism in Cancer and Its Therapeutic Significance
- 1 Mar 2026
- MedComm – Oncology
The Acetyl‐CoA‐NLRX1 Axis Acts as a Key Player in Mitophagy and Drug Resistance
- 14 Feb 2026
- MedComm – Oncology
The Dual Role of Autophagy in Cancer: Mechanisms and Therapeutic Strategies
- 24 Apr 2026
- MedComm – Oncology
X‐Linked Inhibitor of Apoptosis Protein (XIAP) Contributes to ERK1/2‐Mediated Anoikis Resistance in Hepatocellular Carcinoma
- 1 Mar 2026
- MedComm – Oncology
Multifacet Roles of Cellular Senescence in Cancer: Mechanisms and Therapeutic Implications
- 1 Mar 2026
- MedComm – Oncology
Title not available
- 1 Mar 2026
- MedComm – Oncology
The Role of One‐Carbon Metabolism in Cancer and Its Therapeutic Significance
- 1 Mar 2026
- MedComm – Oncology
The Acetyl‐CoA‐NLRX1 Axis Acts as a Key Player in Mitophagy and Drug Resistance
- 14 Feb 2026
- MedComm – Oncology
FAQs on MedComm – Oncology
How many articles did MedComm – Oncology publish last year? 
Who is the publisher of MedComm – Oncology?
